211 related articles for article (PubMed ID: 37781028)
21. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
Yang Z; Cai Z; Yang C; Luo Z; Bao X
EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
[TBL] [Abstract][Full Text] [Related]
22. The role of m6A modification in the biological functions and diseases.
Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
[TBL] [Abstract][Full Text] [Related]
23. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
[TBL] [Abstract][Full Text] [Related]
24. Structural effects of m6A modification of the Xist A-repeat AUCG tetraloop and its recognition by YTHDC1.
Jones AN; Tikhaia E; Mourão A; Sattler M
Nucleic Acids Res; 2022 Feb; 50(4):2350-2362. PubMed ID: 35166835
[TBL] [Abstract][Full Text] [Related]
25. The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.
Jin Z; Liu Y
Heliyon; 2023 Sep; 9(9):e19816. PubMed ID: 37809459
[TBL] [Abstract][Full Text] [Related]
26. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
[TBL] [Abstract][Full Text] [Related]
27. Nuclear Aurora kinase A switches m
Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q
Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747
[TBL] [Abstract][Full Text] [Related]
28. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
29. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain.
Xu C; Wang X; Liu K; Roundtree IA; Tempel W; Li Y; Lu Z; He C; Min J
Nat Chem Biol; 2014 Nov; 10(11):927-9. PubMed ID: 25242552
[TBL] [Abstract][Full Text] [Related]
30. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
31. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
32. METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.
Zhang C; Chen L; Peng D; Jiang A; He Y; Zeng Y; Xie C; Zhou H; Luo X; Liu H; Chen L; Ren J; Wang W; Zhao Y
Mol Cell; 2020 Aug; 79(3):425-442.e7. PubMed ID: 32615088
[TBL] [Abstract][Full Text] [Related]
33. Chromatin-associated YTHDC1 coordinates heat-induced reprogramming of gene expression.
Timcheva K; Dufour S; Touat-Todeschini L; Burnard C; Carpentier MC; Chuffart F; Merret R; Helsmoortel M; Ferré S; Grézy A; Couté Y; Rousseaux S; Khochbin S; Vourc'h C; Bousquet-Antonelli C; Kiernan R; Seigneurin-Berny D; Verdel A
Cell Rep; 2022 Dec; 41(11):111784. PubMed ID: 36516773
[TBL] [Abstract][Full Text] [Related]
34. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of the m
Li X; Yang Y; Chen Z
Metabolism; 2023 Jan; 138():155339. PubMed ID: 36302453
[TBL] [Abstract][Full Text] [Related]
36. m(6)A: Signaling for mRNA splicing.
Adhikari S; Xiao W; Zhao YL; Yang YG
RNA Biol; 2016 Sep; 13(9):756-9. PubMed ID: 27351695
[TBL] [Abstract][Full Text] [Related]
37. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
38. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
39. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
40. The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K-Akt-mTOR signalling.
Liu J; Zuo H; Wang Z; Wang W; Qian X; Xie Y; Peng D; Xie Y; Hong L; You W; Lou H; Luo G; Ren J; Shen B; Zheng J; Wang H; Ju Z
Cell Prolif; 2023 Aug; 56(8):e13410. PubMed ID: 36722312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
